2021 Q4 Form 10-K Financial Statement

#000180245722000007 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $2.880M
YoY Change
Gross Profit -$2.880M
YoY Change
Gross Profit Margin
Selling, General & Admin $4.055M $17.27M $4.520M
YoY Change -10.29% 163.07%
% of Gross Profit
Research & Development $3.519M $9.124M $830.0K
YoY Change 323.98% 120.49%
% of Gross Profit
Depreciation & Amortization $182.0K $544.0K $170.0K
YoY Change 7.06% 13.57%
% of Gross Profit
Operating Expenses $7.755M $26.93M $0.00
YoY Change 140.9%
Operating Profit -$2.880M
YoY Change
Interest Expense $1.514M $2.838M -$22.92M
YoY Change -106.61% 732.26%
% of Operating Profit
Other Income/Expense, Net $11.48M $69.02M -$16.80M
YoY Change -168.32% -460.96%
Pretax Income $5.237M $42.09M -$25.80M
YoY Change -120.3% -238.9%
Income Tax $3.000K
% Of Pretax Income 0.01%
Net Earnings $5.237M $42.09M -$25.80M
YoY Change -120.3% -238.9%
Net Earnings / Revenue
Basic Earnings Per Share $0.42
Diluted Earnings Per Share $37.06K $0.40 -$284.9K
COMMON SHARES
Basic Shares Outstanding 141.3M shares 101.2M shares
Diluted Shares Outstanding 106.2M shares

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $444.1M $444.1M $1.309M
YoY Change 33826.28% 33826.28%
Cash & Equivalents $46.64M $1.309M
Short-Term Investments $397.5M $397.5M $0.00
Other Short-Term Assets $4.466M $4.466M $220.9K
YoY Change 1922.0% 589.2%
Inventory
Prepaid Expenses $220.9K
Receivables
Other Receivables $2.612M $48.00K
Total Short-Term Assets $451.2M $451.2M $2.005M
YoY Change 22402.39% 22402.39%
LONG-TERM ASSETS
Property, Plant & Equipment $57.19M $58.97M $45.10M
YoY Change 26.78% 30.74%
Goodwill
YoY Change
Intangibles $215.0K $258.0K
YoY Change -16.67%
Long-Term Investments $724.7M
YoY Change
Other Assets $62.00K $62.00K $62.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $59.24M $59.24M $45.42M
YoY Change 30.42% 30.42%
TOTAL ASSETS
Total Short-Term Assets $451.2M $451.2M $2.005M
Total Long-Term Assets $59.24M $59.24M $45.42M
Total Assets $510.4M $510.4M $47.43M
YoY Change 976.17% 976.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.451M $2.451M $2.700M
YoY Change -9.22% -9.22%
Accrued Expenses $973.0K $1.253M $593.0K
YoY Change 64.08% 111.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.187M $4.187M $7.764M
YoY Change -46.07% -46.07%
LONG-TERM LIABILITIES
Long-Term Debt $5.189M $5.189M $0.00
YoY Change -14.86%
Other Long-Term Liabilities $2.946M $197.5M $2.500M
YoY Change 17.84% 490.58%
Total Long-Term Liabilities $2.946M $202.7M $2.500M
YoY Change 17.84% 412.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.187M $4.187M $7.764M
Total Long-Term Liabilities $2.946M $202.7M $2.500M
Total Liabilities $206.9M $206.9M $47.31M
YoY Change 337.38% 337.38%
SHAREHOLDERS EQUITY
Retained Earnings -$56.80M -$98.89M
YoY Change -42.56%
Common Stock $16.00K $6.000K
YoY Change 166.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $303.5M $303.5M $122.0K
YoY Change
Total Liabilities & Shareholders Equity $510.4M $510.4M $47.43M
YoY Change 976.17% 976.17%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $5.237M $42.09M -$25.80M
YoY Change -120.3% -238.9%
Depreciation, Depletion And Amortization $182.0K $544.0K $170.0K
YoY Change 7.06% 13.57%
Cash From Operating Activities -$6.427M -$22.04M -$138.3K
YoY Change 4548.15% 303.64%
INVESTING ACTIVITIES
Capital Expenditures -$7.356M $12.27M $650.0K
YoY Change -1231.69% 586.9%
Acquisitions
YoY Change
Other Investing Activities -$399.2M -$399.2M $0.00
YoY Change
Cash From Investing Activities -$406.5M -$411.6M $0.00
YoY Change 19940.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $74.00K
YoY Change 7300.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 274.0K $478.9M 0.000
YoY Change 8116.64%
NET CHANGE
Cash From Operating Activities -6.427M -$22.04M -138.3K
Cash From Investing Activities -406.5M -$411.6M 0.000
Cash From Financing Activities 274.0K $478.9M 0.000
Net Change In Cash -412.7M $45.25M -138.3K
YoY Change 298358.09% -2703.74%
FREE CASH FLOW
Cash From Operating Activities -$6.427M -$22.04M -$138.3K
Capital Expenditures -$7.356M $12.27M $650.0K
Free Cash Flow $929.0K -$34.31M -$788.3K
YoY Change -217.85% 373.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001802457
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-04321
CY2021 dei Entity Registrant Name
EntityRegistrantName
ORIGIN MATERIALS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1388928
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
930 Riverside Parkway
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 10
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
West Sacramento,
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95605
CY2021 dei City Area Code
CityAreaCode
916
CY2021 dei Local Phone Number
LocalPhoneNumber
231-9329
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
899500000 USD
CY2021 dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
141301569 shares
CY2021 dei Auditor Firm
AuditorFirmId
248
CY2021 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2021 dei Auditor Location
AuditorLocation
San Jose, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46637000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1309000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
490000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
565000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
397458000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 USD
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2612000 USD
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
48000 USD
CY2021Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
202000 USD
CY2020Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
0 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3774000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
83000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
451173000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2005000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57185000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45104000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1782000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
215000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
258000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
62000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
62000 USD
CY2021Q4 us-gaap Assets
Assets
510417000 USD
CY2020Q4 us-gaap Assets
Assets
47429000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2451000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2700000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
973000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
593000 USD
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1239000 USD
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3232000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
280000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
380000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
103000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4187000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7764000 USD
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
0 USD
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
906000 USD
CY2021Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
127757000 USD
CY2020Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
0 USD
CY2021Q4 orgn Research And Development Program Liability Noncurrent
ResearchAndDevelopmentProgramLiabilityNoncurrent
6762000 USD
CY2020Q4 orgn Research And Development Program Liability Noncurrent
ResearchAndDevelopmentProgramLiabilityNoncurrent
6197000 USD
CY2021Q4 orgn Redeemable Convertible Preferred Stock Warrants Noncurrent
RedeemableConvertiblePreferredStockWarrantsNoncurrent
0 USD
CY2020Q4 orgn Redeemable Convertible Preferred Stock Warrants Noncurrent
RedeemableConvertiblePreferredStockWarrantsNoncurrent
19233000 USD
CY2021Q4 orgn Assumed Common Stock Warrants Liability Noncurrent
AssumedCommonStockWarrantsLiabilityNoncurrent
52860000 USD
CY2020Q4 orgn Assumed Common Stock Warrants Liability Noncurrent
AssumedCommonStockWarrantsLiabilityNoncurrent
0 USD
CY2021Q4 orgn Stockholder Note Liabilities Noncurrent
StockholderNoteLiabilitiesNoncurrent
5189000 USD
CY2020Q4 orgn Stockholder Note Liabilities Noncurrent
StockholderNoteLiabilitiesNoncurrent
5189000 USD
CY2021Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
5720000 USD
CY2020Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
5517000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1486000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2946000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2500000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
206907000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
47306000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141301569 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141301569 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70266925 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70266925 shares
CY2021Q4 orgn Sponsor Vesting Shares Outstanding
SponsorVestingSharesOutstanding
4500000 shares
CY2021Q4 orgn Sponsor Vesting Shares Issued
SponsorVestingSharesIssued
4500000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
16000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
361542000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98620000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-56797000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98887000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1251000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
384000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
303510000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
123000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
510417000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47429000 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9124000 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4138000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17265000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6563000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
544000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
479000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
26933000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
11180000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
1413000 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2021 us-gaap Interest Expense
InterestExpense
2838000 USD
CY2020 us-gaap Interest Expense
InterestExpense
341000 USD
CY2021 orgn Change In Fair Value Of Derivatives
ChangeInFairValueOfDerivatives
1326000 USD
CY2020 orgn Change In Fair Value Of Derivatives
ChangeInFairValueOfDerivatives
1088000 USD
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
385405000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-395000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1203000 USD
CY2021 orgn Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
4525000 USD
CY2020 orgn Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
18498000 USD
CY2021 orgn Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
75488000 USD
CY2020 orgn Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
0 USD
CY2021 us-gaap Other Nonrecurring Gain
OtherNonrecurringGain
811000 USD
CY2020 us-gaap Other Nonrecurring Gain
OtherNonrecurringGain
805000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
69023000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19122000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
42090000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-30302000 USD
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1712000 USD
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
77000 USD
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
794000 USD
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40455000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29508000 USD
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021 orgn Equity Issuance Costs
EquityIssuanceCosts
37000000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101221781 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62544933 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106237754 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62544933 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
27999000 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1630000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-30302000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
794000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
123000 USD
CY2021 orgn Reclassification Of Stockholders Convertible Notes Payable
ReclassificationOfStockholdersConvertibleNotesPayable
20491000 USD
CY2021 orgn Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiability
54274000 USD
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1635000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
303510000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
42090000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-30302000 USD
CY2021 orgn Reclassification Of Equity To Liability Related To Earn Out Provisions Of Business Combination
ReclassificationOfEquityToLiabilityRelatedToEarnOutProvisionsOfBusinessCombination
-203082000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
77000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5767000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
42090000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
544000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
479000 USD
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
280000 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
5767000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1630000 USD
CY2021 orgn Amortization Of Deb Issuance Costs
AmortizationOfDebIssuanceCosts
14000 USD
CY2020 orgn Amortization Of Deb Issuance Costs
AmortizationOfDebIssuanceCosts
90000 USD
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
380000 USD
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 USD
CY2021 orgn Accretion Of Debt Discount
AccretionOfDebtDiscount
2211000 USD
CY2020 orgn Accretion Of Debt Discount
AccretionOfDebtDiscount
101000 USD
CY2021 orgn Change In Fair Value Of Derivatives
ChangeInFairValueOfDerivatives
1326000 USD
CY2020 orgn Change In Fair Value Of Derivatives
ChangeInFairValueOfDerivatives
1088000 USD
CY2021 orgn Change In Fair Value Of Warrants Liability
ChangeInFairValueOfWarrantsLiability
4525000 USD
CY2020 orgn Change In Fair Value Of Warrants Liability
ChangeInFairValueOfWarrantsLiability
18498000 USD
CY2021 orgn Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
75488000 USD
CY2020 orgn Change In Fair Value Of Earnout Liability
ChangeInFairValueOfEarnoutLiability
0 USD
CY2021 orgn Operating Lease Principal Payments
OperatingLeasePrincipalPayments
295000 USD
CY2020 orgn Operating Lease Principal Payments
OperatingLeasePrincipalPayments
0 USD
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2563000 USD
CY2020 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1007000 USD
CY2021 orgn Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
0 USD
CY2020 orgn Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-87000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3652000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-53000 USD
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
203000 USD
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
256000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3010000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
349000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22043000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5461000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12268000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1786000 USD
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2448316000 USD
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 USD
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2024089000 USD
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 USD
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
25058000 USD
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 USD
CY2021 orgn Payments Of Interest Capitalized To Property Plant And Equipment
PaymentsOfInterestCapitalizedToPropertyPlantAndEquipment
201000 USD
CY2020 orgn Payments Of Interest Capitalized To Property Plant And Equipment
PaymentsOfInterestCapitalizedToPropertyPlantAndEquipment
268000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45253000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1738000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-411638000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2054000 USD
CY2021 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
11707000 USD
CY2020 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
3166000 USD
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
906000 USD
CY2020 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
CY2021 orgn Proceeds From Research And Development Program
ProceedsFromResearchAndDevelopmentProgram
543000 USD
CY2020 orgn Proceeds From Research And Development Program
ProceedsFromResearchAndDevelopmentProgram
2662000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000 USD
CY2021 orgn Proceeds For Business Combination Net Of Issuance Costs Paid
ProceedsForBusinessCombinationNetOfIssuanceCostsPaid
467530000 USD
CY2020 orgn Proceeds For Business Combination Net Of Issuance Costs Paid
ProceedsForBusinessCombinationNetOfIssuanceCostsPaid
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
478948000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5829000 USD
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14000 USD
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-52000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1874000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3612000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47127000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1874000 USD
CY2021 orgn Conversion Of Stockholder Convertible Notes Payable To Common Stock
ConversionOfStockholderConvertibleNotesPayableToCommonStock
20493000 USD
CY2020 orgn Conversion Of Stockholder Convertible Notes Payable To Common Stock
ConversionOfStockholderConvertibleNotesPayableToCommonStock
0 USD
CY2021 orgn Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock
ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock
54267000 USD
CY2020 orgn Reclassification Of Redeemable Convertible Preferred Stock Warrants To Common Stock
ReclassificationOfRedeemableConvertiblePreferredStockWarrantsToCommonStock
0 USD
CY2021 orgn Reclassification Of Contingently Issued Equity To Liability
ReclassificationOfContingentlyIssuedEquityToLiability
203082000 USD
CY2020 orgn Reclassification Of Contingently Issued Equity To Liability
ReclassificationOfContingentlyIssuedEquityToLiability
0 USD
CY2021 orgn Net Assets Assumed From Business Combination
NetAssetsAssumedFromBusinessCombination
81364000 USD
CY2020 orgn Net Assets Assumed From Business Combination
NetAssetsAssumedFromBusinessCombination
0 USD
CY2021 orgn Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities
DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities
2196000 USD
CY2020 orgn Debt Discount Related To Derivative Liability Under Noncash Investing And Financing Activities
DebtDiscountRelatedToDerivativeLiabilityUnderNoncashInvestingAndFinancingActivities
0 USD
CY2021 orgn Business Combination Transaction Costs Accrued But Not Paid
BusinessCombinationTransactionCostsAccruedButNotPaid
609000 USD
CY2020 orgn Business Combination Transaction Costs Accrued But Not Paid
BusinessCombinationTransactionCostsAccruedButNotPaid
0 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2062000 USD
CY2021 orgn Proceeds For Business Combination
ProceedsForBusinessCombination
444600000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1874000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported amounts of expenses during the reporting periods. Estimates made by the Company include, but are not limited to, those related to the valuation of common stock and valuation of convertible preferred stock warrants prior to the Business Combination, valuation of the earnout liability, valuation of assumed common stock warrants liability, carrying amount and useful lives of property and equipment and intangible assets, impairment assessments, marketable securities, stock-based compensation expense, probabilities of achievement of performance conditions on performance stock awards, among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47127000 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and marketable securities accounts with a financial institution where, at times, deposits exceed federal insurance limits. Management believes that the Company is not exposed to significant credit risk as the Company’s deposits are held at financial institutions that management believes to be of high credit quality. The Company has not experienced any losses on these deposits.
CY2019Q4 orgn Escrow Deposit Fair Value
EscrowDepositFairValue
1300000 USD
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
300000 USD
CY2020Q4 us-gaap Escrow Deposit
EscrowDeposit
300000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46637000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1309000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
490000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
565000 USD
CY2021 orgn Grants Received
GrantsReceived
0 USD
CY2020 orgn Grants Received
GrantsReceived
200000 USD
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q4 orgn Percent Of Occurrence Of A Tender Offer Or Exchange Of Our Stockholders
PercentOfOccurrenceOfATenderOfferOrExchangeOfOurStockholders
0.50
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2021 orgn Accretion Expense For Debt Issuance Cost
AccretionExpenseForDebtIssuanceCost
2200000 USD
CY2020 orgn Accretion Expense For Debt Issuance Cost
AccretionExpenseForDebtIssuanceCost
100000 USD
CY2021 orgn Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
3 plan
CY2021Q2 orgn Business Combination Reversion Recapitalization Conversion Ratio
BusinessCombinationReversionRecapitalizationConversionRatio
2.11
CY2021 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
200000 USD
CY2021 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
36700000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
295000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2007000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
397458000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
346300000 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 USD
CY2021Q2 orgn Proceeds For Business Combination Net Of Issuance Costs Paid
ProceedsForBusinessCombinationNetOfIssuanceCostsPaid
467530000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1800000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1800000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
399170000 USD
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
2024100000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
97438000 USD
CY2021Q4 orgn Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Two
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearTwo
146197000 USD
CY2021Q4 orgn Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Two Years
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterTwoYears
153802000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
397458000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64725000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52146000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7540000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7042000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
57185000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45104000 USD
CY2020 us-gaap Depreciation
Depreciation
500000 USD
CY2021 us-gaap Depreciation
Depreciation
500000 USD
CY2021Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
900000 USD
CY2020Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
700000 USD
CY2021Q4 orgn Cumulative Translation Adjustment
CumulativeTranslationAdjustment
-100000 USD
CY2020Q4 orgn Cumulative Translation Adjustment
CumulativeTranslationAdjustment
900000 USD
CY2016Q4 orgn Proceeds From Collaborative Agreement
ProceedsFromCollaborativeAgreement
500000 USD
CY2021 us-gaap Other Income
OtherIncome
500000 USD
CY2020 us-gaap Other Income
OtherIncome
600000 USD
CY2016Q4 orgn Proceeds From Collaborative Agreement
ProceedsFromCollaborativeAgreement
500000 USD
CY2018Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1500000 USD
CY2021 orgn Number Of Offtake Supply Agreements
NumberOfOfftakeSupplyAgreements
4 agreement
CY2021 orgn Number Of Terminable Offtake Supply Agreements
NumberOfTerminableOfftakeSupplyAgreements
2 agreement
CY2021Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
10900000 USD
CY2020Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
10700000 USD
CY2020 us-gaap Loss Contingency Damages Awarded Value
LossContingencyDamagesAwardedValue
900000 USD
CY2021 orgn Offtake Agreement Exercise Period
OfftakeAgreementExercisePeriod
P1Y
CY2021 orgn Offtake Agreement Purchase Period
OfftakeAgreementPurchasePeriod
P10Y
CY2016Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
5000000 USD
CY2021 orgn Earnout Shares Post Triggering Event Period
EarnoutSharesPostTriggeringEventPeriod
P10D
CY2021Q4 orgn Common Stock Earnout Shares
CommonStockEarnoutShares
25000000 shares
CY2021Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
4500000 shares
CY2019Q2 orgn Lesser Eligible Costs Percentage
LesserEligibleCostsPercentage
0.1848
CY2019Q2 orgn Lesser Eligible Costs
LesserEligibleCosts
23000000 CAD
CY2019Q2 orgn Funding Repayment Period
FundingRepaymentPeriod
P15Y
CY2019Q2 orgn Development Program Liability Maximum Repayment Ratio Compared To Actual Funding Received
DevelopmentProgramLiabilityMaximumRepaymentRatioComparedToActualFundingReceived
1.25
CY2021Q2 orgn Development Program Liability Funding Reduction Percentage
DevelopmentProgramLiabilityFundingReductionPercentage
0.50
CY2019Q2 orgn Minimum Costs Of Commercial Plants
MinimumCostsOfCommercialPlants
500000000 CAD
CY2019Q2 orgn Commercial Plants Constructed And Operational Period
CommercialPlantsConstructedAndOperationalPeriod
P30M
CY2021Q4 orgn Funding Liability
FundingLiability
6800000 USD
CY2020Q4 orgn Funding Liability
FundingLiability
6200000 USD
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
35476667 shares
CY2021Q4 orgn Assumed Common Stock Warrants Liability Noncurrent
AssumedCommonStockWarrantsLiabilityNoncurrent
52900000 USD
CY2021 orgn Change In Fair Value Of Gain Loss Assumed Warrants
ChangeInFairValueOfGainLossAssumedWarrants
30500000 USD
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2021Q4 orgn Sponsor Vesting Shares Outstanding
SponsorVestingSharesOutstanding
4500000 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
18467109 shares
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P4Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7667247 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10244399 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4130184 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2150941 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
49260254 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6600000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7300000 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
43645000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-29162000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1554000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1141000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42091000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30303000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000 USD
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24899000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18400000 USD
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
390000 USD
CY2020Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
0 USD
CY2021Q4 orgn Deferred Tax Assets Leasing Arrangments
DeferredTaxAssetsLeasingArrangments
341000 USD
CY2020Q4 orgn Deferred Tax Assets Leasing Arrangments
DeferredTaxAssetsLeasingArrangments
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
230000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
149000 USD
CY2021Q4 orgn Deferred Tax Assets Property Plant And Equipment And Intangibles
DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibles
89000 USD
CY2020Q4 orgn Deferred Tax Assets Property Plant And Equipment And Intangibles
DeferredTaxAssetsPropertyPlantAndEquipmentAndIntangibles
114000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25949000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18663000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
344000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
0 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
344000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25605000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18663000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
6900000 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1900000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
97800000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
36800000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
6700000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.013
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2021 orgn Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items Percent
EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItemsPercent
-0.333
CY2020 orgn Effective Income Tax Rate Reconciliation Warrants Bcf And Other Equity Items Percent
EffectiveIncomeTaxRateReconciliationWarrantsBCFAndOtherEquityItemsPercent
-0.131
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.156
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.064
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.016
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
324000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42090000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30302000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
68000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.015
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021 orgn Lessee Operating Lease Number Of Amended Leases
LesseeOperatingLeaseNumberOfAmendedLeases
2 lease
CY2021 us-gaap Lease Cost
LeaseCost
392000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1782000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y5M8D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.028
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
271000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2062000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
327000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
300000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
269000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
257000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
264000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
528000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1945000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
179000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
280000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1486000 USD
CY2021 orgn Royalty Payment For License Agreement
RoyaltyPaymentForLicenseAgreement
0 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
42090000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-30302000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101221781 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62544933 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106237754 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62544933 shares
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
2342466 shares
CY2020 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
0 shares
CY2021Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1481531 shares
CY2021Q4 orgn Common Stock Performance Shares
CommonStockPerformanceShares
2137500 shares
CY2021Q4 orgn Common Stock Earnout Shares
CommonStockEarnoutShares
25000000 shares
CY2021Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
4500000 shares

Files In Submission

Name View Source Status
0001802457-22-000007-index-headers.html Edgar Link pending
0001802457-22-000007-index.html Edgar Link pending
0001802457-22-000007.txt Edgar Link pending
0001802457-22-000007-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orgn-20211231.htm Edgar Link pending
orgn-20211231.xsd Edgar Link pending
orgn-20211231xexx231.htm Edgar Link pending
orgn-20211231xexx311.htm Edgar Link pending
orgn-20211231xexx312.htm Edgar Link pending
orgn-20211231xexx313.htm Edgar Link pending
orgn-20211231xexx321.htm Edgar Link pending
orgn-20211231xexx45.htm Edgar Link pending
orgn-20211231_cal.xml Edgar Link unprocessable
orgn-20211231_def.xml Edgar Link unprocessable
orgn-20211231_g1.jpg Edgar Link pending
orgn-20211231_g2.jpg Edgar Link pending
orgn-20211231_g3.jpg Edgar Link pending
orgn-20211231_htm.xml Edgar Link completed
orgn-20211231_lab.xml Edgar Link unprocessable
orgn-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending